Montelukast (Antaluko, Montelukast LHC)
Montelukast
LHC Pharmaceuticals (Pty) Ltd
Registration
- Applicant
- LHC Pharmaceuticals (Pty) Ltd
- Certificate holder
- LHC Pharmaceuticals (Pty) Ltd
- Registrations
- 6
- Schedule source
- Consolidated Schedules 06 July 2026
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Antaluko 4 Each tablet contains MONTELUKAST SODIUM EQUIVALENT TO MONTELUKAST 4,0 mg | 10mgFilm-coated tablets | 45045545/10.2.2/0455Approved 31 January 2024 | Registered | S3 | PIPIL |
| Antaluko 5 Each tablet contains MONTELUKAST SODIUM EQUIVALENT TO MONTELUKAST 5,0 mg | 10mgFilm-coated tablets | 45045645/10.2.2/0456Approved 31 January 2024 | Registered | S3 | PIPIL |
| Antaluko 10 EACH TABLET CONTAINS :MONTELUKAST SODIUM EQUIVALENT TO MONTELUKAST 10,0 mg | 10mgFilm-coated tablets | 45045745/10.2.2/0457Approved 31 January 2024 | Cancelled | S3 | PIPIL |
| Montelukast 4 LHC Each tablet contains MONTELUKAST SODIUM EQUIVALENT TO MONTELUKAST 4,0 mg | 10 mg/200 mg/350 mgFilm-coated tablets, | 45045845/10.2.2/0458Approved 31 January 2024 | Registered | S3 | PIPIL |
| Montelukast 5 LHC Each tablet contains MONTELUKAST SODIUM EQUIVALENT TO MONTELUKAST 5,0 mg | 10 mg/200 mg/350 mgFilm-coated tablets, | 45045945/10.2.2/0459Approved 31 January 2024 | Registered | S3 | PIPIL |
| Montelukast LHC 10 EACH TABLET CONTAINS :MONTELUKAST SODIUM EQUIVALENT TO MONTELUKAST 10,0 mg | 10 mg/200 mg/350 mgFilm-coated tablets, | 45046045/10.2.2/0460Approved 31 January 2024 | Registered | S3 | PIPIL |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Montelukast sodium equivalent to montelukast
S3: Montelukast
Consolidated Schedules 06 July 2026, line 3967
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
2-[1-[[(1R)-1-[3-[(E)-2-(7-Chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid
Drag to rotate. Structure from PubChem CID 5281040.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.